Åke Borg
Impact in
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
- Oncology top 0.1%
Papers in
- Cancer Research 114
- Cancer Genomics and Diagnostics 87
- Breast Cancer Treatment Studies 23
- Genetics 153
- BRCA gene mutations in cancer 98
- Genomic variations and chromosomal abnormalities 56
- Co-authors
- Hakan Lars Olsson (57 shared papers)Mårten Fernö (36 shared papers)Markus Ringnér (26 shared papers)Johan Vallon‐Christersson (51 shared papers)Lao H. Saal (30 shared papers)Johan Staaf (51 shared papers)Jorma J Isola (20 shared papers)Óskar Þór Jóhannsson (15 shared papers)
- Journals
- Nature Communications (18 papers)Genes Chromosomes and Cancer (16 papers)Breast Cancer Research (13 papers)Breast Cancer Research and Treatment (11 papers)International Journal of Cancer (11 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Åke Borg
339 papers receiving 42.0k citations
Åke Borg's Hit Papers
Peers
Comparison fields: 5 of 182
- Cancer Research 14.7k
- Oncology 11.2k
- Genetics 10.9k
- Molecular Biology 21.4k
- Pathology and Forensic Medicine 4.4k
Countries citing papers authored by Åke Borg
This map shows the geographic impact of Åke Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åke Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åke Borg more than expected).
Fields of papers citing papers by Åke Borg
This network shows the impact of papers produced by Åke Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åke Borg. The network helps show where Åke Borg may publish in the future.
Co-authors
The 25 scholars most cited alongside Åke Borg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 344 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families Hit paper breakdown → | 1998 | 2460 |
| 2 | Visualization and analysis of gene expression in tissue sections by spatial transcriptomics Hit paper breakdown → | 2016 | 2369 |
| 3 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 4 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 5 | Landscape of somatic mutations in 560 breast cancer whole-genome sequences Hit paper breakdown → | 2016 | 1649 |
| 6 | Mutational Processes Molding the Genomes of 21 Breast Cancers Hit paper breakdown → | 2012 | 1476 |
| 7 | The Life History of 21 Breast Cancers Hit paper breakdown → | 2012 | 1092 |
| 8 | High-definition spatial transcriptomics for in situ tissue profiling Hit paper breakdown → | 2019 | 809 |
| 9 | HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures Hit paper breakdown → | 2017 | 780 |
| 10 | PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma Hit paper breakdown → | 2005 | 757 |
| 11 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 12 | 2006 | 627 | |
| 13 | Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. | 2001 | 579 |
| 14 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 550 |
| 15 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 476 |
| 16 | The CD44+/CD24-phenotype is enriched in basal-like breast tumors Hit paper breakdown → | 2008 | 475 |
| 17 | 2007 | 447 | |
| 18 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 419 |
| 19 | HER-2/neu amplification predicts poor survival in node-positive breast cancer. | 1990 | 404 |
| 20 | 2015 | 402 |
About Åke Borg
Åke Borg is a scholar working on Cancer Research, Genetics, Oncology, Pathology and Forensic Medicine and Molecular Biology, having authored 344 papers that have together received 43.0k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (98 papers), Cancer Genomics and Diagnostics (87 papers), Genomic variations and chromosomal abnormalities (56 papers), Genetic factors in colorectal cancer (45 papers), Cancer-related Molecular Pathways (23 papers), Breast Cancer Treatment Studies (23 papers), RNA Research and Splicing (19 papers) and Ovarian cancer diagnosis and treatment (18 papers). The work is most often cited by research in Cancer Research (14.7k citations), Oncology (11.2k citations), Genetics (10.9k citations), Molecular Biology (21.4k citations) and Pathology and Forensic Medicine (4.4k citations). Åke Borg has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Hakan Lars Olsson, Mårten Fernö, Markus Ringnér, Johan Vallon‐Christersson, Lao H. Saal, Johan Staaf, Jorma J Isola, Óskar Þór Jóhannsson, Pär‐Ola Bendahl and D. Killander. Their work appears in journals such as Nature Communications, Genes Chromosomes and Cancer, Breast Cancer Research, Breast Cancer Research and Treatment and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.